Location History:
- Watertown, MD (US) (2023)
- Watertown, MA (US) (2013 - 2024)
Company Filing History:
9 out of 9 
6 out of 19 
5 out of 1,735 
Years Active: 2013-2025
Title: John M. Geremia: Innovator in Glycan Therapeutics
Introduction: John M. Geremia, based in Watertown, MA, is a prominent inventor with a focus on advancements in glycan therapeutics. With an impressive portfolio of 22 patents, Geremia's contributions to the field of biotechnology demonstrate his dedication to enhancing health outcomes through innovative solutions.
Latest Patents: Among his latest patents, Geremia has developed therapeutic compositions that utilize glycans for cancer therapy. His patent on "Glycan therapeutic compositions and related methods thereof" includes preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements, and medical foods, showcasing methods for their application in treating cancer. Another significant patent focuses on "Methods of producing glycan polymers," which describes preparations of glycan polymers and their formulations as pharmaceutical compositions, medical foods, and feed additives. This invention also incorporates micronutrients and various beneficial agents to enhance efficacy.
Career Highlights: Throughout his career, Geremia has made significant strides within the biotechnology sector. He has held key positions at companies such as Kaleido Biosciences, Inc. and Cadena Bio, Inc., where he has collaborated on pioneering projects aimed at improving health through glycan-based innovations. His extensive experience and insight into the complexities of glycan therapeutics have established him as a leader in his field.
Collaborations: John M. Geremia has had the privilege of working alongside notable professionals such as Jared Silverman and Yvonne J. Yamanaka. These collaborations have been fundamental in advancing research and driving innovation in glycan therapies, reflecting Geremia's commitment to teamwork and shared goals in scientific discovery.
Conclusion: In conclusion, John M. Geremia stands out as a visionary inventor in the realm of glycan therapeutics. His 22 patents represent a significant contribution to biotechnology, particularly in the development of innovative therapeutic solutions. With a career marked by impactful collaborations and dedicated research, Geremia continues to be a driving force in transforming health care through innovation.